Ibandronate sodium salt (CAS 138844-81-2)

Ibandronate sodium salt, a bisphosphonate compound, is extensively studied in scientific research, particularly in the fields of bone biology, osteoporosis, and drug development. This chemical exerts its effects through inhibition of osteoclast-mediated bone resorption, a process crucial for maintaining bone density and strength. Ibandronate functions by binding to hydroxyapatite crystals in bone tissue, where it is internalized by osteoclasts and disrupts their function, leading to decreased bone turnover and increased bone mineral density. Researchers utilize Ibandronate sodium salt as a pharmacological tool to investigate the molecular mechanisms underlying bone remodeling and osteoclast activity regulation. Additionally, it serves as a lead compound in the development of novel bisphosphonate derivatives with enhanced efficacy and selectivity for bone-targeted therapies. Furthermore, Ibandronate sodium salt finds applications in studies to evaluate its effects on bone metabolism and fracture healing in animal models of osteoporosis and bone diseases. Its pivotal role in bone research and drug discovery highlights its significance as a tool for advancing our understanding of bone physiology and developing novel strategies for bone-related disorders.